Inimex Pharmaceuticals is a clinical-stage company focused on the development and commercialization of innate defense regulators.
Inimex Pharmaceuticals, Inc. is a clinical stage company focused on the development and commercialization of Innate Defense Regulators (IDRs), novel first in class drugs that selectively trigger the body's innate defenses without causing inflammation.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 2, 2008 | Series B | $22M | 2 | — | — | Detail |
Dec 8, 2004 | Series A | $2M | 2 |
![]() |
— | Detail |
Jul 6, 2004 | Series A | $4.50M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
![]() |
Yes | Series A |
![]() |
— | Series B |
![]() |
— | Series B |